LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

Search

Stevanato Group SpA

Chiusa

SettoreSettore sanitario

16.13 1.57

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

15.8

Massimo

16.32

Metriche Chiave

By Trading Economics

Entrata

10M

49M

Vendite

23M

303M

P/E

Media del settore

26.246

110.024

EPS

0.162

Rendimento da dividendi

0.35

Margine di Profitto

16.205

Dipendenti

5,521

EBITDA

10M

73M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+48.84% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.35%

2.26%

Utili prossimi

5 mar 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-2.4B

4.4B

Apertura precedente

14.56

Chiusura precedente

16.13

Notizie sul Sentiment di mercato

By Acuity

50%

50%

165 / 351 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bullish Evidence

Stevanato Group SpA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

17 feb 2026, 23:44 UTC

Azioni calde

Stocks to Watch: La-Z-Boy, Palo Alto Networks, Caesars

17 feb 2026, 23:20 UTC

Utili

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps -- Update

17 feb 2026, 22:57 UTC

Utili

Santos Fiscal Year Net Profit Falls 33%, Nears Start of Alaska Project

17 feb 2026, 21:59 UTC

Utili

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps

17 feb 2026, 23:54 UTC

Discorsi di Mercato

Nikkei May Rise as Fears About AI Disruption Ease -- Market Talk

17 feb 2026, 23:54 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

17 feb 2026, 23:54 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

17 feb 2026, 23:45 UTC

Discorsi di Mercato

Suncorp's Outperformance of IAG Could Be Hard to Sustain -- Market Talk

17 feb 2026, 23:19 UTC

Utili

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 feb 2026, 23:15 UTC

Utili

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 feb 2026, 22:58 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Netflix Would Operate Warner's Studios, HBO Largely the Same -- Market Talk

17 feb 2026, 22:58 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Steel: Board Committed to Optimizing Value For Shareholders

17 feb 2026, 22:57 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Steel to Consider Revised SGH, Steel Dynamics Takeover Bid

17 feb 2026, 22:50 UTC

Acquisizioni, Fusioni, Takeovers

Agnico-Eagle Mines Acquired 662,780 Common Shrs of Maple Gold Mines at C$2.45 Per Common Shr >AEM.T

17 feb 2026, 22:44 UTC

Utili

Palo Alto Reports Strong Earnings. Its Stock Is Down. -- Barrons.com

17 feb 2026, 22:42 UTC

Utili

Santos FY Net Profit Falls 33%, Nears Start of Alaska Project

17 feb 2026, 22:36 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Netflix Sarandos: Paramount Causing Confusion Around Warner Deal -- Market Talk

17 feb 2026, 22:36 UTC

Utili

Santos Final Dividend 10.3 U.S. Cents/Security

17 feb 2026, 22:36 UTC

Utili

Santos FY Underlying Profit US$898 Million, Down 25%

17 feb 2026, 22:35 UTC

Utili

Santos FY Revenue US$4.94 Billion, Down 8%

17 feb 2026, 22:35 UTC

Utili

Correct: Santos FY Net Profit US$818 Million, Down 33%

17 feb 2026, 22:35 UTC

Acquisizioni, Fusioni, Takeovers

Berkshire Buys New York Times Stock; Sells Apple, Bank of America, Amazon In 4Q -- Barrons.com

17 feb 2026, 22:34 UTC

Utili

Santos FY Net Profit US$818 Billion, Down 33%

17 feb 2026, 22:02 UTC

Acquisizioni, Fusioni, Takeovers

Berkshire Pares Stakes in Apple and BofA, Adds New York Times Position -- Update

17 feb 2026, 21:50 UTC

Acquisizioni, Fusioni, Takeovers

Steel Dynamics: SGH Would Buy BlueScope, On-sell North American Operations to SDI, As Earlier Proposed

17 feb 2026, 21:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Tech, Media & Telecom Roundup: Market Talk

17 feb 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

17 feb 2026, 21:49 UTC

Acquisizioni, Fusioni, Takeovers

Steel Dynamics Says Revised Proposal Continues to Present Highly Strategic Opportunity For SDI Shareholders

17 feb 2026, 21:48 UTC

Acquisizioni, Fusioni, Takeovers

Steel Dynamics: BlueScope Offer a 56% Premium to 52-Week Volume Weighted Average Price

17 feb 2026, 21:48 UTC

Acquisizioni, Fusioni, Takeovers

Steel Dynamics: Consideration To Be Comprised Entirely of Cash

Confronto tra pari

Modifica del prezzo

Stevanato Group SpA Previsione

Obiettivo di Prezzo

By TipRanks

48.84% in crescita

Previsioni per 12 mesi

Media 23.83 USD  48.84%

Alto 30 USD

Basso 17.5 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Stevanato Group SpA - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

4 ratings

2

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

21.56 / 22.61Supporto e resistenza

A breve termine

Weak Bullish Evidence

A termine intermedio

Weak Bearish Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

165 / 351 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat